Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: December 2006
-
By Jason Derry — Exelixis Inc. has announced a collaboration agreement with Bristol-Myers Squibb that the companies hope will result in the discovery and eventual commercialization of compounds to treat cancer. Under the agreement, Exelixis will identify potential small molecule drugs candidates, and will carry the drugs through preclinical development. BMS will have…
-
By Jason Derry — As we reported on December 6, the Thailand government recently issued a compulsory license on Merck's AIDS drug, Efavirenz. We also noted that Merck was not happy about the action because Thailand failed to contact Merck prior to making the decision. Today, the Intellectual Property Owners Association (IPO) reported…
-
By Jason Derry — In a press release published this morning, Eli Lilly and Co. has announced that it has raised its bid for Icos Corp. to $2.3 billion. The proposed deal will be considered by Icos shareholders in a meeting scheduled for December 26. According to its website, Icos is a biotechnology…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma patent cases. A few interesting cases will be selected for periodic monitoring, providing our readers with an opportunity to follow the progress of these cases. Novartis Corp. et. a. v. Lupin Ltd. et al.1:06-cv-03338;…
-
By Christopher P. Singer — In a December 14, 2006 press release, Mirus Bio Corporation announced that U.S. Patent No. 7,148,205, titled "Intravascular Delivery of Non-Viral Nucleic Acid" has been granted by the U.S. Patent Office. According to Mirus Bio, the patent covers a technology for the administration of molecules that can induce RNA…
-
A two-day conference entitled Biotechnology 2007 will be held in San Francisco on January 29-30, 2007. The conference is presented by Law Seminars International, and will cover a wide variety of topics related to legal and business aspects of the biotechnology industry. According to LSI's website, by attending the conference "you will learn": • New…
-
The American Conference Institute has organized a conference dedicated to patent portfolio managing and strategies. The event will be held on February 27-28, 2007 in New York, NY. The two-day conference will cover topics such as: • Making the Critical Determination of When R&D Becomes IP; • Protecting Market Share Through Competitive Intelligence; • Investigating…
-
By Sherri Oslick — Earlier this week we reported on Savient Pharmaceuticals, Inc. v. Sandoz, Inc. and Upsher-Smith Laboratories, Inc., 2:06-cv-05782, filed December 4, 2006 in the District Court of New Jersey. Judge Sheridan had granted, then vacated, the temporary restraining order sought by Savient to prevent Sandoz from taking any actions to market,…
-
By Christopher P. Singer — Internet heavyweight Google has recently launched Google Patent Search, a beta version of a patent searching feature. Currently, the search program covers issued U.S. Patents from the 1790s through the middle of 2006. As the company discusses on the FAQ page relating to this service, it hopes to…
-
By Jason Derry — Innovation Asset Group provides web-based applications for managing intellectual assets. According to a December 13th press release, the company's major product, Decipher®, has seen a "notable adoption" of use from life sciences companies. Decipher® is designed to help companies manage several aspects of their intellectual property. According to its…
Patent Docs 